Hi peaceAKKI,
I don't believe the interim IIb results is only for 6 patients, as has mentioned. That would be fairly useless, and not much of an update.
The 6 patient reference relates to a secondary study on how Cvac behaves or works when it comes in contact with the mucin 1 protein. The safety data is for all patients recuited.
prima biomed to release interim cvac clinical , page-23
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.3¢ |
Change
0.008(2.54%) |
Mkt cap ! $439.4M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.5¢ | 30.0¢ | $131.3K | 433.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 374343 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 181014 | 11 |
View Market Depth
| Last trade - 11.15am 22/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |